Literature DB >> 12796247

Patterns of care for open-angle glaucoma in managed care.

Allen M Fremont1, Paul P Lee, Carol M Mangione, Kanika Kapur, John L Adams, Steven L Wickstrom, José J Escarce.   

Abstract

OBJECTIVES: To describe patterns of care for primary open-angle glaucoma (POAG) and assess conformance with the American Academy of Ophthalmology's Preferred Practice Pattern (PPP).
METHODS: We obtained administrative, survey, and eye care records data on 395 working-age patients with POAG enrolled in 6 managed care plans between 1997 and 1999. We assessed processes of care at the initial and follow-up visits, control of intraocular pressure (IOP), intervals between visits and visual field tests, and adjustments in therapy.
RESULTS: We found high rates of performance on most recommended processes during initial evaluations, although only 53% of patients received an optic nerve head photograph or drawing and only 1% had a target IOP level documented. Recommended processes were performed at 80% to 97% of follow-up visits. Using loose criteria for control, IOP was controlled in 66% of follow-up visits for patients with mild glaucoma and 52% of visits for patients with moderate to severe glaucoma. Intervals between visits and visual field tests were generally consistent with PPP recommendations. Adjustments in therapy were more likely with worse control of IOP, although adjustments occurred in only half of visits where the IOP was 30 mm Hg or higher.
CONCLUSIONS: Our study suggests that, in many respects, patients with POAG are receiving care that is consistent with the PPP. However, care is falling short on several key aspects, and POAG may be undertreated relative to standards for IOP control established in recent clinical trials.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796247     DOI: 10.1001/archopht.121.6.777

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  24 in total

Review 1.  Role of optic nerve imaging in glaucoma clinical practice and clinical trials.

Authors:  David S Greenfield; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2008-03-04       Impact factor: 5.258

2.  Ability of non-ophthalmologist doctors to detect eyes with occludable angles using the flashlight test.

Authors:  Carolina Pelegrini Barbosa Gracitelli; Bruno Landgren; Flávia Bracale Graciani; Aline Kátia Siqueira Sousa; Augusto Paranhos; Tiago Santos Prata
Journal:  Int Ophthalmol       Date:  2013-10-01       Impact factor: 2.031

3.  Intra-session repeatability of iridocorneal angle measurements provided by a Scheimpflug photography-based system in healthy eyes.

Authors:  Clara Ruiz-Belda; David P Piñero; Pedro Ruiz-Fortes; Roberto Soto-Negro; Myriam Moya; Rafael J Pérez-Cambrodí; Alberto Artola
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-15       Impact factor: 3.117

4.  Why Do People (Still) Go Blind from Glaucoma?

Authors:  Remo Susanna; Carlos Gustavo De Moraes; George A Cioffi; Robert Ritch
Journal:  Transl Vis Sci Technol       Date:  2015-03-09       Impact factor: 3.283

5.  A comparison of cup-to-disc ratio estimates by fundus biomicroscopy and stereoscopic optic disc photography in the Tema Eye Survey.

Authors:  J C Mwanza; D S Grover; D L Budenz; L W Herndon; W Nolan; J Whiteside-de Vos; G Hay-Smith; J R Bandi; K A Bhansali; L A Forbes; W J Feuer; K Barton
Journal:  Eye (Lond)       Date:  2017-04-07       Impact factor: 3.775

6.  Compliance With Primary Open-angle Glaucoma and Primary Open-angle Glaucoma Suspect Preferred Practice Patterns in a Retail-based Eye Clinic.

Authors:  Jordan Stanley; Carrie E Huisingh; Thomas A Swain; Gerald McGwin; Cynthia Owsley; Christopher A Girkin; Lindsay A Rhodes
Journal:  J Glaucoma       Date:  2018-12       Impact factor: 2.503

7.  Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma.

Authors:  Sung Woo Cho; Joon Mo Kim; Ki Ho Park; Chul Young Choi
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

8.  Establishing a Regional Glaucoma Physician Collaborative to Improve Quality of Care.

Authors:  Joshua R Ehrlich; Jeffrey N Wentzloff; Nauman R Imami; Taylor S Blachley; Joshua D Stein; Paul P Lee; Jennifer S Weizer
Journal:  Am J Ophthalmol       Date:  2017-05-05       Impact factor: 5.258

9.  First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results.

Authors:  Jordana K Schmier; David W Covert
Journal:  Clin Ophthalmol       Date:  2010-05-14

10.  First-year treatment costs among new initiators of topical prostaglandin analogs.

Authors:  Jordana K Schmier; David W Covert; Alan L Robin
Journal:  Clin Ophthalmol       Date:  2009-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.